DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
177 hedge funds and large institutions have $944M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 53 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3% less capital invested
Capital invested by funds: $972M → $944M (-$28.6M)
80% less call options, than puts
Call options by funds: $85K | Put options by funds: $434K
Holders
177
Holding in Top 10
3
Calls
$85K
Puts
$434K
Top Buyers
| 1 | +$11M | |
| 2 | +$9.88M | |
| 3 | +$9.44M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$7.79M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$6.83M |
Top Sellers
| 1 | -$48.7M | |
| 2 | -$10.4M | |
| 3 | -$8.81M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$6.39M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$5.51M |